Skip to main content
Signal8

Boston Megan

SEC insider (Form 3/4/5 filer). CIK 0001808923. Executive Director at Benitec Biopharma Inc. (BNTC). 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 18, 2025. Located in HAYWARD, CA.

Companies Boston Megan has filed insider reports for

  • Benitec Biopharma Inc. (BNTC): Director, Officer, Executive Director
Boston Megan profile photo

Boston Megan

CIK: 0001808923

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Benitec Biopharma Inc. logo
BNTC

Benitec Biopharma Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Benitec Biopharma Inc. logo
    BNTC

    Benitec Biopharma Inc.

    Nov 18, 2025
    Award

    Options (right to buy)

    Direct
    200K shares-
  • Benitec Biopharma Inc. logo
    BNTC

    Benitec Biopharma Inc.

    Dec 9, 2024
    Award

    Options (right to buy)

    Direct
    720K shares-

1-2 of 2